carfilzomib and irinotecan in relapsed small cell lung cancer
Published 5 years ago • 298 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
2:31
resilient: liposomal irinotecan in relapsed sclc
-
2:50
daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma
-
3:43
carfilzomib combinations in endeavor and forte
-
3:14
endeavor: carfilzomib new standard in multiple myeloma?
-
52:37
know your myeloma therapy: carfilzomib (kyprolis) with dr. harsh parmar
-
10:31
carfilzomib use in multiple myeloma
-
6:56
daratumuab, carfilzomib and dexamethasone increases survival in patients with relapsed/refractor...
-
4:11
updates from aspire and endeavor
-
1:04
treatment options for high risk relapsed/refractory multiple myeloma
-
3:23
maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma
-
1:28
carfilzomib and panobinostat for r/r multiple myeloma: phase i results
-
2:12
dr. fakhri on the use of carfilzomib in multiple myeloma
-
1:57
dr. paul on the role of carfilzomib in relapsed/refractory multiple myeloma
-
1:56
carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma
-
1:53
dr. spigel on pembrolizumab/chemo combo in first-line nsclc
-
6:44
combining carfilzomib with krd vs ktd in ndmm patients with high-risk cytogenetics
-
1:39
phase iii aspire study of carfilzomib, lenalidomide and dexamethasone in relapsed myeloma
-
0:47
dr. keith stewart discusses the efficacy of carfilzomib in the aspire trial
-
2:25
dr. davies on carfilzomib dosage in multiple myeloma